Murphy Nicole insider trades
Murphy Nicole has filed 20 Form 4s with the SEC that we hold, all for Biogen INC. (BIIB), as Head of Pharm Ops and Tech. Across all of them we count 1 purchase worth $585 and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($585) and 0 sales ($0). The largest single trade was a purchase of 3 shares of Biogen INC. worth $585, dated 2026-02-12. The first filing on our record is dated 2022-02-14 and the latest 2026-02-17.
Biogen INC. (BIIB)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2026-02-12 | P, purchase reported on Form 4 | 3 | $585 | 2026-02-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1910644) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms